Strategic Targeting for Optimal Prevention of Cancer
Recruiting now
Conditions studied: Early Detection of Cancer
In brief
The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.
Key facts
- Study ID
- NCT03897374
- Run by
- ClinLogic LLC
- People needed
- 120000
- Starts
- 2025-03-26
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2026-03-19
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Study subjects may be included in the Clinical Trial if they meet all of the following inclusion criteria:
- individuals, ages 65 years or older;
- must have met medical necessity for hereditary cancer genomic testing and allowed the physician to test based on medical necessity;
- hereditary cancer diagnostic test was ordered by a physician related to individual subject care considerations.
- study subject has or had cancer
- study subject has at least one family member with cirrent or past cancer
You may not qualify if…
- Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;
- study subject is unable to provide an accurate history due to mental incapacity
- study subject is currently abusing illicit and/or prescription drugs;
Where it is running
- Sunbeam Clinical — Prosper, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.